Genetics Policy Institute

THE GENETICS POLICY Institute (GPI) is a nonprofit education and advocacy organization whose primary purpose is to defend the rights of researchers to engage in stem cell research and the rights of patients to benefit from therapies developed through stem cell research. GPI is located in the United States, with headquarters in Wellington, Florida, and an office in Washington, D.C., but conducts research, education and policy activities on a worldwide scale.

The origins of GPI lie in the Clonaid trial of 2002, in which Bernard Siegel, J.D., founder and executive director of GPI, played a key role in exposing Clonaid as a fraud. Clonaid, a U.S. company associated with the Raëlian Movement headquartered in Montreal, CA, claimed to have produced a human clone that they called ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles